https://www.prnewswire.com/in/news-releases/stemedica-cell-technologies-reports-positive-data-in-phase-i-iia-study-of-allogeneic-stem-cells-for-ischemic-stroke-877550753.html
Stemedica Cell Technologies Reports Positive Data in Phase I/IIa Study of Allogeneic Stem Cells for...
/PRNewswire/ -- Stemedica Cell Technologies, Inc., a clinical-stage biopharmaceutical company developing allogeneic progenitor cell and protein therapeutics...
https://www.stemedica.com/
Stemedica | Stemedica Cell Technologies, Inc.
celltechnologiesinc